Veritone Inc vs GeneDx Holdings Corp — how do they compare? Veritone Inc trades at $1.13 (market cap $97.60M), while GeneDx Holdings Corp trades at $61.92 (market cap $1.80B). The key difference: GeneDx Holdings Corp is far larger — about 18.4× Veritone Inc's market cap, and GeneDx Holdings Corp is trading nearer its 52-week high, Veritone Inc nearer its low. Which is the better fit depends on your goals.
| VERI | WGS | |
|---|---|---|
Market Cap | $97.60M | $1.80B |
Sector | Technology | Technology |
52-Week High | $8.39 | $167.51 |
52-Week Low | $1.02 | $34.51 |
Enterprise Value | $129.63M | $1.80B |
Trailing returns across standard periods
Veritone is a leading provider of enterprise AI software and solutions, centered on its proprietary AI operating system, aiWARE™. The platform orchestrates a vast ecosystem of machine learning models to transform unstructured data—such as audio, video, and text—into actionable intelligence. Serving the media, entertainment, and public sectors, Veritone is a critical infrastructure partner for organizations looking to monetize data archives and operationalize AI at scale.
Read more on VERI →GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →